Generative Data Intelligence

Tag: Alzheimer’s disease

VC Lindy Fishburne on the seemingly sudden democratization of science

Deep science investor Lindy Fishburne cofounded the seed- and early-stage venture firm Breakout Ventures several years ago, after cofounding Breakout Labs within the...

Deep Learning Models Have Advantages for Neuroscience, Researchers Find 

By John P. Desmond, AI Trends Editor   Neuroscientists using AI models to simulate the brain are learning more about how the...

Teaser Trailer Arrives for Animated Poem Namoo

Baobab Studios has become one of the premier creators of animated content for virtual reality (VR) headsets, from 2017’s Invasion! to the more...

Seattle biotech startup AltPep raises $23.1M to tackle Alzheimer’s and related diseases

AltPep, a Seattle-based biotech startup tackling amyloid protein disorders, has raised $23.1 million in a Series A funding round. The venture spun out the...

A Newfound Source of Cellular Order in the Chemistry of Life

Imagine packing all the people in the world into the Great Salt Lake in Utah — all of us jammed shoulder to shoulder,...

Brain Cell DNA Refolds Itself to Aid Memory Recall

More than a century ago, the zoologist Richard Semon coined the term “engram” to designate the physical trace a memory must leave in...

IBM: Our AI correctly predicts onset of Alzheimer’s 71% of the time, better than standard clinical tests

Machine-learning algorithms analyzing human communication can predict whether someone will develop Alzheimer’s disease more accurately than standard biomedical screening, say IBM and Pfizer....

AI in Healthcare: A review of innovative startups

AI in Healthcare: A review of innovative startups = Previous post Next post =>    Tags: AI, Coronavirus, COVID-19, Healthcare,...

Love in the time of thermo

An 81-year-old medical doctor has fallen off a ladder in his house. His pet bird hopped out of his reach, from branch to...

Evidation Health raises $45M to expand into virtual care

The company has now raised over $106 million in venture funding   Thanks to technologies like EHR systems and wearable devices, there's...

A Renaissance of Genomics and Drugs Is Extending Human Longevity

The causes of aging are extremely complex and unclear. But with longevity clinical trials increasing, more answers—and questions—are emerging than ever before. With the...

Study finds path for addressing Alzheimer’s blood-brain barrier impairment

By developing a lab-engineered model of the human blood-brain barrier (BBB), neuroscientists at MIT’s Picower Institute for Learning and Memory...

Latest Intelligence

spot_img
spot_img
spot_img